FDA NEWS

Amgen osteoporosis drug could face FDA scrutiny - Forbes
Amgen 's experimental osteoporosis drug denosumab could have difficulty gaining Food and Drug Administration approval in its initial try, due to a higher incidence of infections compared with placebo seen in some patients, according to an
Source: www.forbes.com

Tomatoes not alone on FDA's radar - Detroit Free Press
WASHINGTON -- As salmonella cases continue to climb, the government is investigating whether tainted tomatoes really are to blame for the record outbreak -- or if the problem is with another ingredient or a warehouse that is contaminating newly
Source: www.freep.com

Critics blast feds' legal shields for manufacturers - Chicago Tribune
WASHINGTON — Bridget Robb's 6-year-old daughter watched fearfully one morning last December as her mother nearly passed out in pain. A wire that connected a defibrillator in Robb's chest had broken, causing it to send waves of powerful electric
Source: www.chicagotribune.com

AspenBio Pharma Commences FDA Clinical Trial for AppyScore(TM - MSN MoneyCentral
AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has officially initiated a clinical trial to support the FDA 510(k) application for the
Source: news.moneycentral.msn.com